Skip to Main Content

Paper Details

PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
BMJ
32
2022
Author NameAffiliation
Per Olav VandvikClinical Effectiveness Research Group, Institute of Health Society, University of Oslo
Per Olav VandvikMAGIC Evidence Ecosystem Foundation.
Irbaz Bin RiazMayo Clinic
Irbaz Bin RiazHarvard Medical School
  • 1 - 4

Datasets

Release 1.2